Resection of Locally Advanced Pancreatic Neoplasms after Neoadjuvant Chemotherapy with Nab-Paclitaxel and Gemcitabine following FOLFIRINOX Failure

The incidence of pancreatic cancer has dramatically increased over the past years, but the prognosis has not improved. Between 30 and 40% of tumors are considered locally advanced, essentially due to vascular involvement. In recent years, new chemotherapy protocols with high response rates have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Sarah, Ayav, Ahmet, Lopez, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624236/
https://www.ncbi.nlm.nih.gov/pubmed/29033758
http://dx.doi.org/10.1159/000478722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624236/
https://www.ncbi.nlm.nih.gov/pubmed/29033758
http://dx.doi.org/10.1159/000478722

Ejemplares similares